Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment

NCT02809118 is registered in ClinicalTrials.gov with Auris Medical, Inc. as lead sponsor.

NCT NCT02809118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02809118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Lead sponsor
Auris Medical, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2016
Completion date
February 28, 2018
Enrollment
56 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

hearing loss, idiopathic sudden sensorineural